AgriLabs, the largest U.S. animal health marketing and distribution business, announces it has entered into the vaccine manufacturing business with a new USDA-licensed facility in Lincoln, Nebraska. AgriLabs has also acquired Lincoln-based Antelope Valley Bios and Benchmark Biolabs, and Benchmark's ownership interest of VaxLiant. With these moves, AgriLabs, along with its new business subsidiaries, now offers complete concept-to-commercialization services for vaccines used in swine, cattle, poultry and other species.
"By adding state-of-the-art manufacturing capabilities to our U.S. marketing and sales operations, we can deliver more value to veterinarians and producers both domestically and worldwide," said Steve Schram, AgriLabs chief executive officer, at a ribbon-cutting event on Wednesday that included several state and city officials. "With the need for alternatives to antibiotics, vaccines are critical to the long term health and efficiency of food animal production," Schram said.
The swine market will be the first target for the new facilities, with a focus on custom-made vaccines.
AgriLabs' three fully owned subsidiaries in Lincoln - Antelope Valley Bios, Benchmark Biolabs and VaxLiant - will continue to operate as stand-alone business entities.